Group 1 - The core point of the news is that Huilong Pharmaceutical has seen a significant increase in its stock price, rising 5.02% to 19.86 CNY per share, with a total market capitalization of 8.413 billion CNY and a cumulative increase of 6.96% over the past four days [1] - Huilong Pharmaceutical, established on October 12, 2010, specializes in the research, production, and sales of oncology drugs and complex injectable drugs, with 97.27% of its revenue coming from drug sales [1] - The trading volume for Huilong Pharmaceutical reached 136 million CNY, with a turnover rate of 2.03% [1] Group 2 - Among the top shareholders of Huilong Pharmaceutical, Ping An Medical Health Mixed A Fund (003032) has entered the top ten, holding 6.8378 million shares, which is 1.99% of the circulating shares, and has gained approximately 649.59 thousand CNY in floating profit today [2] - During the four-day increase, the floating profit for Ping An Medical Health Mixed A Fund reached 841.05 thousand CNY [2] - The fund was established on November 24, 2017, with a current size of 2.028 billion CNY and has achieved a year-to-date return of 6.44% [2]
汇宇制药股价涨5.02%,平安基金旗下1只基金位居十大流通股东,持有683.78万股浮盈赚取649.59万元